Syros Pharmaceuticals, Inc.
SYRS
Revenue
387.00k
▼-3.38M▼-89.71%
3 Months ChangeAssets
85.00M
▼-21.73M▼-20.36%
3 Months ChangeLiabilities
96.12M
▼-16.96M▼-15.00%
3 Months ChangeFree Cash Flow
-37.14M
▼-6.99M▼-23.19%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2025-03-04
Form 8-K
ID: 0001193125-25-045638
2025-02-28
Form 8-K
ID: 0001193125-25-042498
2025-01-08
Form 8-K
ID: 0001193125-25-003483
2024-12-06
Form 8-K
ID: 0001193125-24-271959
2024-11-18
Form 8-K
ID: 0001193125-24-260421
2024-11-13
Form 8-K
ID: 0001193125-24-256586
2024-10-31
Form 10-Q
ID: 0000950170-24-119236
2024-09-05
Form 8-K
ID: 0001193125-24-213668
2024-08-12
Form 8-K
ID: 0001193125-24-198969
2024-07-31
Form 10-Q
ID: 0000950170-24-088224